PathwayVoyager fills a niche for environments with limited hardware and software resources that still require a significant and meaningful way to perform small and large scale pathway mapping projects from varying data sources.
These results are indicative of the majority of all large-scale pathways (both intra as well as interhemispheric tracts) to be present at term, together with an adult-like small-world modular architecture.
Enhanced technologies can increase our understanding of the interactions between the host and its resident microbiota and their respective roles in IBD from both a large-scale pathway view and at the metabolic level.
Therefore, large-scale pathway annotation transfer between these 3 organisms can extend our current knowledge of their signaling pathways.
Open-access databases are thus the main repositories of the large-scale pathway reaction and interaction data necessary for cellular-scale systems modelling.
Given the nature of experiments, however, it is not even always certain that all information for interested variables can be gained from experiments and not all metabolites in the large-scale pathway can be measured.
Moreover, except these few databases, there is no significant development observed in the other databases to develop a common computational platform dedicated for data curation, annotation and large-scale pathway analysis process.
However, to perform large-scale pathway analysis, automated pathway annotations or to extract the non-redundant pathway data from various resources, dynamic web-based API service (available in KEGG, REACTOME, PANTHER, WikiPathways, CPDB, etc). is useful (see Supplementary Tables S2 and S3).
Hopefully, this work can provide some insights to tackle the challenging problem of assessment of combination drug therapy effct in a large scale signaling pathways.
We hope that this work can provide insights to tackle the challenging problem of assessment of combinational drug therapy effect in a large scale signaling pathway.
Indeed, a large-scale pathways-based association study in ALS recently failed to exhibit significant findings for other candidate pathways [60].
